A retrospective analysis of ketamine intravenous therapy for post-traumatic stress disorder in real-world care settings.
Psychiatry Research August 20, 2025 L. Mcinnes, Robert M. Berman, Matthew Worley et al.
OBJECTIVE The study evaluated the effectiveness of Ketamine Intravenous Therapy (KIT) in reducing post-traumatic stress disorder (PTSD) and depression symptoms, using electronic health record data from outpatient psychiatric patients with PTSD. METHOD We analyzed data from 8,136 patients diagnosed with PTSD, 87 % (N = 7,070) of whom also had comorbid depression. Symptom severity was measured...